Trademark owner · USPTO register · rebuilt nightly

Glaxosmithkline Biologicals SA

145 live US trademarks, filing since 1990. The 42nd largest trademark holder in Class 5 (pharmaceuticals). 18 new applications filed this year.

On the register as GlaxoSmithKline Biologicals SA · Glaxosmithkline Biologicals S.A.

Live marks
145
registered + pending
Registered
124
on the Principal Register
Pending
21
applications in progress
Filed in 2026
18
12 intent to use
Classes used
6
of 45 Nice classes
First filing
1990
36 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 138 of 145 live marks are in Class 5. Medical & beauty services (Class 44) is next with 4.
Filing faster than usual: 18 applications so far in 2026 against a yearly average of 9.8.
New products ahead: 12 of the 18 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
Entering Class 9 (electronics & software): first filings this year in a class with no earlier Glaxosmithkline Biologicals SA marks.
7 registrations have a maintenance filing due in the next 12 months, 2 already in the grace period.
Filing activityapplications per year, by filing date
0 34 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 18 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Glaxosmithkline Biologicals SA filed most recently.

MarkClassFiledBasisStatusSerial
BREKFLUVA 5 Sep 16, 2026 — pending 50111431
FLUHANA 5 Sep 16, 2026 — pending 50111432
JEXFLUVA 5 Sep 14, 2026 intent to use published · closes Dec 10 50106129
POXAVAQ 5 Jul 10, 2026 intent to use published · closes Dec 10 99932736
VARCYLDI 5 Jul 10, 2026 intent to use published · closes Dec 10 99933306
VARZIELD 5 Jul 10, 2026 intent to use published · closes Dec 10 99933309
VYMZAV 5 Jul 10, 2026 intent to use published · closes Dec 10 99933712
VAXVARCI 5 Jul 10, 2026 intent to use published · closes Dec 10 99933723
VARCYNVA 5 Jul 10, 2026 intent to use published · closes Dec 10 99933725
POXGARDVY 5 Jul 10, 2026 intent to use published · closes Dec 10 99933727
Recently registeredlast 12 months
VAXBEMVO · Cl. 5 · Reg. 8,437,065
Sep 15, 2026
AXFLUNA · Cl. 5 · Reg. 8,123,335
Feb 3, 2026
BRELLAFLU · Cl. 5 · Reg. 8,123,337
Feb 3, 2026
EXFLUNAY · Cl. 5 · Reg. 8,123,338
Feb 3, 2026
BREKFLUNA · Cl. 5 · Reg. 8,123,339
Feb 3, 2026
EXTASHIELD · Cl. 5 · Reg. 8,123,340
Feb 3, 2026
FLUPRIMVA · Cl. 5 · Reg. 8,123,341
Feb 3, 2026
FLUTRUXEV · Cl. 5 · Reg. 8,123,342
Feb 3, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Maintenance windows aheadnext 12 months · from registration dates
SIMPLIFLU · Reg. 6,069,891 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 2, 2026
Jun 2, 2025 → Jun 2, 2026
BOOSTRIX · Reg. 6,082,491 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 23, 2026
Jun 23, 2025 → Jun 23, 2026
MENHIBRIX · Reg. 3,226,716 · registered Apr 2007
Section 8 & 9 renewal (year 20)
Apr 10, 2026 → Apr 10, 2027
INFANRIX · Reg. 2,095,412 · registered Sep 1997
Section 8 & 9 renewal (year 30)
Sep 9, 2026 → Sep 9, 2027
SHINGLES DOESN'T CARE · Reg. 6,486,462 · registered Sep 2021
Section 8 declaration (years 5–6)
Sep 14, 2026 → Sep 14, 2027
SHINGLES DOESN'T CARE. SHINGRIX PROTECTS. · Reg. 6,493,629 · registered Sep 2021
Section 8 declaration (years 5–6)
Sep 21, 2026 → Sep 21, 2027
MENVEO · Reg. 3,307,617 · registered Oct 2007
Section 8 & 9 renewal (year 20)
Oct 9, 2026 → Oct 9, 2027

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 5Full ranking →
Names on the registerwhat this page merges, and what it leaves out
GlaxoSmithKline Biologicals SA · 122 live marks
included
Glaxosmithkline Biologicals S.A. · 23 live marks
included

Spellings are merged when they differ only in punctuation or legal suffix. Anything else stays separate rather than guessed.

Common questions

About Glaxosmithkline Biologicals SA trademarks.

How many trademarks does Glaxosmithkline Biologicals SA have?

145 live US trademarks as of October 23, 2026: 124 registered and 21 pending applications. 18 were filed in 2026 so far.

What does Glaxosmithkline Biologicals SA sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 138 live marks). Also medical & beauty services (Class 44) and paper & printed matter (Class 16).

Who owns the HAVRIX trademark?

HAVRIX is owned by Glaxosmithkline Biologicals SA. It was registered on July 21, 1992 (Reg. No. 1701341) and is live. The same owner holds 144 other live US marks.

When did Glaxosmithkline Biologicals SA first file a trademark?

Its oldest live US filing dates from 1990: HAVRIX, filed March 26, 1990.

Know the morning after Glaxosmithkline Biologicals SA files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.